Jounce Therapeutics Inc. (JNCE) Rose 10.29% or 0.72 To Price $7.72 On Thursday


Jounce Therapeutics Inc. (JNCE) rose 10.29% or 0.72 to $7.72. It is about 709019 shares traded, which is 239.47% compare to the average total volume 296083. The market cap of JNCE is $250.77 million. The year to date change is -37.48%. The 52 week price range is from $6.56 to $29.25. Price of JNCE have changed 1.16% during last week. It have changed -13.04% over last month, -65.60% over last 3 months, -70.25% over last 6 months and -44.13% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for JNCE is 7.92. It is 2.59% above current price. The 200-day Moving Averages for JNCE is 15.86. It is 105.44% above current price. The 52-week High is 29.25. It is 278.89% from the current price. The 52-week Low is 6.56. It is -15.03% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of JNCE is 8.66 on 2018-07-13. Short % to float is 12.88%. There are some statistics of JNCE. It is has market cap $250.77 million. The share outstanding is 32.48 million. The average volume is 296083. The revenue is 38.37M. The percent of top 15 Institution holding is 49.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of JNCE is -18.88%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of JNCE is -8.61%.


Tags:

Share this post